U.S., April 23 -- An application to own the trademark for 'VEXLAYRI' has been filed on Oct. 15, 2024.
Owner(s):
Teva Pharmaceutical Industries Ltd.; 124 Dvora HaNevi'a St.,, , ISRAEL
Goods and/or Services:
For: Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urog...